Lupus anticoagulant in human immunodeficiency virus -infected patients on highly active antiretroviral therapy

<b>Background:</b> Lupus anticoagulant (LA) is a heterogeneous group of antibodies that causes a variety of clinical and laboratory effects; has been described in infections such as human immunodeficiency virus. LA has not been previously described in Nigerians with human immunodeficien...

Full description

Bibliographic Details
Main Authors: Awodu Omolade, Olayemi Edeghonghon, Bazuaye Godwin, Onunu Abel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2010-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2010;volume=53;issue=1;spage=47;epage=49;aulast=Awodu